Document is current
Any future updates will be listed below
-
Authors
Schneider, Michael P.
Cullen, Amy E.
Pangonyte, Justina
Skelton, Jason
Major, Harvey
Van Oudenhove, Elke
Garcia, Maria J.
Chaves Urbano, Blas
Piskorz, Anna M.
Brenton, James D.
Macintyre, Geoff
Markowetz, Florian http://orcid.org/0000-0002-2784-5308
-
Funding
Funding for this research was provided by:
Cancer Research UK Cambridge Institute, University of Cambridge (A17197, A19274, C14303)
H2020 Marie Skłodowska-Curie Actions (766030-CONTRA-H2020-MSCA-ITN-2017)
- License Information
-
More Information
Article History
Received: 15 June 2023
Accepted: 22 February 2024
First Online: 4 March 2024
Declarations
:
: The review history is available as Additional file InternalRef removed.
: Andrew Cosgrove was the primary editor of this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.
: Not applicable.
: Not applicable.
: AMP, FM, GM, and JDB are founders, directors and shareholders of Tailor Bio Ltd. AEC is an employee and shareholder of Tailor Bio Ltd.
